Dr. Carmella Evans-Molina is the Eli Lilly Professor of Pediatric Diabetes at Indiana University (IU) School of Medicine, where she serves as Director of the IU Center for Diabetes and Metabolic Diseases and the Indiana Diabetes Research Center. She is a staff physician at the Roudebush VA Medical Center and Program Leader of the Diabetes Research Program in the Herman B Wells Center for Pediatric Research. 

Dr. Evans-Molina serves as Vice Chair of Type 1 Diabetes TrialNet – the world's leading international research network dedicated to T1D prevention – where she has led the Beta Cell Working Group, chaired the Long-Term Investigative Follow-Up (LIFT) Study, and is currently leading a clinical trial testing JAK inhibitors to preserve beta cell function in newly diagnosed T1D. Her work has been recognized with the 2023 Outstanding Scientific Achievement Award from the American Diabetes Association. Her expertise spans beta cell biology, T1D biomarker development, and the design and execution of immune intervention trials. 

She is Co-Executive Director of nPOD, Co-PI of the NIH Integrated Islet Distribution Program, and an investigator in RADIANT (the NIH-funded Rare and Atypical Diabetes Network). Her research is funded by the NIH, VA, Breakthrough T1D, and the Helmsley Charitable Trust. She serves as Associate Editor for the journal Diabetes. 

Dr. Evans-Molina earned her M.D. from Marshall University and her Ph.D. in Pharmacology from the University of Virginia. She completed residency in internal medicine at Massachusetts General Hospital and fellowship in endocrinology and metabolism at the University of Virginia.